Mongolian Medicine Oncology

Department Introduction: The Department of Mongolian Hematology and Oncology of Inner Mongolia International Mongolian Medicine Hospital was founded in the early 1980s. In 1998, a tumor treatment project was added, called the Department of Hematology and Oncology of Mongolian Medicine. The department currently has 88 beds and more than 40 medical staff, including 3 chief physicians, 1 deputy chief physician, 11 attending physicians and resident physicians, including 8 master's students, 1 doctoral student, and 1 master's student. In 2002, it was rated as a key department of the Autonomous Region Health Department. Director Hanggai Bater was named a young and middle-aged academic leader. In 2009, it was again rated as a key department of the autonomous region. In 2011, it was rated as a key discipline of Mongolian medicine for hematology by the State Administration of Traditional Chinese Medicine. With the joint efforts of all medical staff, the department is actively exploring new areas of Mongolian medicine in the treatment of blood diseases and tumor diseases. More than 15,000 patients with Henoch-Schonlein purpura are treated every year. It has a certain reputation throughout North China. It is welcomed by the society and the majority of patients. It mainly treats various hematological diseases such as Henoch-Schonlein purpura, thrombocytopenic purpura, aplastic anemia, myelodysplastic syndrome, chronic myeloid leukemia, multiple myeloma, polycythemia vera, paroxysmal nocturnal hemoglobinuria and other hematological diseases. The department has been using the technology developed by Hanggai Bater since 1998.Specialized preparations such as New Honghua Bawei Pills, Hualiu Pills, Jiedu Pills, Boer Qiwei Pills, and Tegexi No. II developed by the director have been put into clinical use and have achieved good clinical effects. Among them, the new Honghua Bawei Pill has applied for a patent. The clinical efficacy of these drugs is recognized by the majority of patients. It has opened up a new way for Mongolian medicine to treat blood diseases and tumor diseases. Third-level ward rounds by the department team